|
|
|
Insider
Information: |
Damaj Bassam |
Relationship: |
President and CEO, Dir... |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
1,610,987 |
|
Indirect Shares
|
327,100 |
|
|
Direct
Value |
$171,248 |
|
|
Indirect Value
|
$34,771 |
|
|
Total
Shares |
1,938,087 |
|
|
Total
Value |
$206,019 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Seelos Therapeutics Inc |
SEEL |
President and CEO, Dir... |
2012-08-23 |
1,610,987 |
2011-01-31 |
327,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SEEL |
Seelos Therapeutics Inc |
Chief Executive OfficerOfficer |
|
2009-12-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
921,361 |
|
- |
|
SEEL |
Seelos Therapeutics Inc |
Chief Executive OfficerOfficer |
|
2009-12-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
388,433 |
|
- |
|
SEEL |
Seelos Therapeutics Inc |
President and CEO |
|
2010-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500,000 |
5,887,559 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
President and CEO |
|
2010-10-07 |
5 |
GD |
$0.00 |
$0 |
D/D |
47,000 |
828,876 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
President and CEO |
|
2011-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
908,876 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
President and CEO |
|
2011-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
124,509 |
535,040 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
President and CEO |
|
2012-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
249,002 |
1,610,987 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Chief Executive Officer |
|
2010-01-11 |
4 |
A |
$0.17 |
$34,382 |
I/I |
204,657 |
593,090 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Chief Executive Officer |
|
2010-01-11 |
4 |
A |
$0.17 |
$81,554 |
D/D |
485,443 |
1,406,804 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
President and CEO |
|
2010-03-15 |
4 |
A |
$0.17 |
$500,767 |
D/D |
2,980,755 |
4,387,559 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
President and CEO |
|
2010-03-15 |
4 |
A |
$0.17 |
$211,117 |
I/I |
1,256,650 |
1,849,740 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
President and CEO |
|
2010-06-21 |
4 |
A |
$2.52 |
$1,218,097 |
D/D |
483,372 |
875,876 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
President and CEO |
|
2010-06-21 |
4 |
A |
$2.52 |
$513,536 |
I/I |
203,784 |
327,100 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
President and CEO |
|
2012-08-20 |
4 |
B |
$2.69 |
$4,034 |
D/D |
1,500 |
1,361,985 |
2.73 |
- |
|
SEEL |
Seelos Therapeutics Inc |
President and CEO |
|
2012-08-21 |
4 |
B |
$2.77 |
$2,105 |
D/D |
760 |
1,611,747 |
2.73 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|